www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

C3b/iC3b/C3d, Human, mAb 1H8

Catalogue number:
HM2287-20UG
Supplier:
Size:
20 µg _$$_
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£132.00 Shipping is calculated in checkout
Applications:

Flow cytometry, Immuno precipitation, Western blot

Product Description:

The monoclonal antibody 1H8 recognizes Complement Factor C3b/iC3b/C3d, it specifically binds human C3 as well as the breakdown products C3b, iC3b and C3dg. C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. People with C3 deficiency are susceptible to bacterial infection.One form of C3-convertase, also known as C4b2a, is formed by a heterodimer of activated forms of C4 and C2. It catalyzes the proteolytic cleavage of C3 into C3a and C3b, generated during activation through the classical pathway as well as the lectin pathway. C3a is an anaphylotoxin and the precursor of some cytokines such as ASP, and C3b serves as an opsonizing agent. Factor I can cleave C3b into C3c and C3d, the latter of which plays a role in enhancing B cell responses. In the alternative complement pathway, C3 is cleaved by C3bBb, another form of C3-convertase composed of activated forms of C3 (C3b) and factor B (Bb). Once C3 is activated to C3b, it exposes a reactive thioester that allows the peptide to covalently attach to any surface that can provide a nucleophile such as a primary amine or a hydroxyl group. Activated C3 can then interact with factor B. Factor B is then activated by factor D, to form Bb. The resultant complex, C3bBb, is called the alternative pathway (AP) C3 convertase.C3bBb is deactivated in steps. First, the proteolytic component of the convertase, Bb, is removed by complement regulatory proteins having decay-accelerating factor (DAF) activity. Next, C3b is broken down progressively to first iC3b, then C3c + C3dg, and then finally C3d. Factor I is the protease that performs these cuts with CR1 as cofactor. Clone 1H8 recognize separate, non-overlapping epitopes on C3 fragments. Levels of C3 in the blood may be measured to support or refute a particular medical diagnosis. For example, low C3 levels are associated with some types of kidney disease such as post-infectious glomerulonephritis and shunt nephritis.

HM2287-20UG C3b/iC3b/C3d, Human, mAb 1H8
HM2287-20UG C3b/iC3b/C3d, Human, mAb 1H8
Details Cat number & supplier Size Price
C3b/iC3b, Human, mAb 3E7 HM2286-20UG · Hycult Biotech
HM2286-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
MPO, Human, mAb B7 HM2288-20UG · Hycult Biotech
HM2288-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
C3b/iC3b, Human, mAb 5G9 HM2285-20UG · Hycult Biotech
HM2285-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
Alpha-1-antitrypsin, Human, mAb 2C1 HM2289-20UG · Hycult Biotech
HM2289-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
GILT, Human, mAb MaP.IP30 HM2284-20UG · Hycult Biotech
HM2284-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
NOD1, Human, mAb 2A10 HM2290-20UG · Hycult Biotech
HM2290-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
Properdin, Human, mAb SIM 295-9.3.4 HM2283-20UG · Hycult Biotech
HM2283-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
NOD2, Human, mAb hNOD2.017 HM2291-20UG · Hycult Biotech
HM2291-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
Properdin, Human, mAb 2.9 HM2282-20UG · Hycult Biotech
HM2282-20UG
Hycult Biotech
20 µg £132.00
20 µg
view
DAF, Human, mAb 1C6 HM2280-20UG · Hycult Biotech
HM2280-20UG
Hycult Biotech
20 µg £132.00
20 µg
view